Figure 1.
Figure 1. Human engraftment 12 weeks after transplantation. B-lymphoid–restricted engraftment of human lin– CD3– SP mPB cells (A) and myeloid-lymphoid engraftment of human lin– CD3– non-SP mPB cells (B). FACS analysis of bone marrow cells of mice 12 weeks after transplantation. Cells were stained with anti–human CD45/71-PE, CD15/66b-FITC, CD56-PE, CD3-FITC, CD19/20-PE, CD34-FITC, and CD33-PE. B-lymphoid cells were detected in 4 of 19 mice after transplantation of 300 to 3000 lin– CD3– SP mPB cells in 3 independent experiments.

Human engraftment 12 weeks after transplantation. B-lymphoid–restricted engraftment of human lin CD3 SP mPB cells (A) and myeloid-lymphoid engraftment of human lin CD3 non-SP mPB cells (B). FACS analysis of bone marrow cells of mice 12 weeks after transplantation. Cells were stained with anti–human CD45/71-PE, CD15/66b-FITC, CD56-PE, CD3-FITC, CD19/20-PE, CD34-FITC, and CD33-PE. B-lymphoid cells were detected in 4 of 19 mice after transplantation of 300 to 3000 lin CD3 SP mPB cells in 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal